• R Ruano Pérez, A C Rebollo Aguirre, P García-Talavera San Miguel, R Díaz Expósito, S Vidal-Sicart, J M Cordero García, D Carrera Salazar, M E Rioja Martín, and Grupo de Trabajo de Cirugía Radioguiada de la SEMNIM.
• Servicio de Medicina Nuclear, Hospital Clínico Universitario de Valladolid, Valladolid, España. Electronic address: rruano@saludcastillayleon.es.
• Rev Esp Med Nucl Imagen Mol (Engl Ed). 2018 Jan 1; 37 (1): 63-70.

AbstractThe role of the selective sentinel node biopsy (SNB) is increasing in relevance in breast cancer women with indication of neoadjuvant chemotherapy (NAC). The Radiosurgery Working Group of the SEMNIM is aware of the necessity of establishing the need for SNB before or after NAC, and also how to manage patients with axillary node-negative or node-positive. There is sufficient data to assess that the SNB with radioisotope techniques are feasible and safe in all these scenarios. An adequate axilla evaluation prior to surgery and the possibility of marking prior to NAC the nodes infiltrated must be the two main pillars to guarantee the success of the SNB. It has been shown that to incorporate the SNB in breast cancer women with indication of NAC increases the rate of a conservative treatment of the axilla that will be a clear benefit for these patients.Copyright © 2017 Elsevier España, S.L.U. y SEMNIM. All rights reserved.

26 keywords...

hide…